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Phosphoinositides are critical regulators in cell biology. Phosphatidylinositol 4,5-
bisphosphate, also known as PI(4,5)P2 or PIP2, was the first variety of phosphoinositide to
enter in the T cell signaling scene. Phosphatidylinositol bis-phosphates are the substrates
for different types of enzymes such as phospholipases C (β and γ isoforms) and phospho-
inositide 3-kinases (PI3K class IA and IB) that are largely involved in signal transduction.
However until recently, only a few studies highlighted phosphatidylinositol monophos-
phates as signaling molecules. This was mostly due to the difficulty of detection of some
of these phosphoinositides, such as phosphatidylinositol 5-phosphate, also known as PI5P.
Some compelling evidence argues for a role of PI5P in cell signaling and/or cell trafficking.
Recently, we reported the detection of a PI5P increase upon TCR triggering. Here, we
describe the current knowledge of the role of PI5P inT cell signaling.The future challenges
that will be important to achieve in order to fully characterize the role of PI5P in T cell
biology, will be discussed.
Keywords: PI5P, PtdIns5P, phosphoinositide,T cell signaling, Dok proteins
INTRODUCTION
Phosphoinositides (PIs) are well known regulators of cell biol-
ogy processes. Their polar inositol head group can be reversely
phosphorylated on three different positions on the inositol ring
(D3, D4, and D5). This can give rise to seven different phos-
phoinositides from the unphosphorylated one (PI) to the famous
PI(3,4,5)P3 or PIP3. Phosphoinositides are anchored to cell mem-
branes via two fatty acid chains inserted to the lipid bilayer. The
membrane localization of phosphoinositides allows them to play a
very important role in controlling protein localization within the
cell, making them important players in cell signaling pathways.
From the 1950s to early 1980s, several research teams con-
tributed to identify PI(4,5)P2 cleavage by the phospholipase
C gamma (PLCγ) into Diacylglycerol (DAG) and Inositol tri-
phosphate (IP3) (Berridge and Irvine, 1984). Subsequently these
products lead to the activation of protein kinases C (PKC) and the
release of Ca2+. These studies provided the first evidence that PIs
could be of great importance for cell signaling. Later, the detection
of increased level of PI(3,4,5)P3 upon oncogenic transformation
and receptor tyrosine kinase (RTK) engagement led to the iden-
tification of the phosphoinositide 3 kinase (PI3K) enzymes. This
introduced poly-phosphoinositides into many cell signaling path-
ways and identified a new common signaling pathway, PI3K/AKT,
that is still under intense investigation (Whitman et al., 1988;
Courtney et al., 2010; So and Fruman, 2012).
Until recently only few studies highlighted mono-PIs as sig-
naling molecules in cell biology. This is mostly due to the difficult
nature of detecting them (Pendaries et al., 2005). But several recent
compelling studies argue for an important role of these mono-PIs
in cell signaling. Among these mono-PIs, the phosphatidylinositol
5-phosphate PI5P has been the most recently identified PIs. Its late
identification is mainly due to the difficulty in separating it from its
close isomer PI4P in High-Performance-Liquid-Chromatography
(HPLC) (Rameh et al., 1997; Sarkes and Rameh, 2010). Since then,
several studies highlighted PI5P as a new potential important
signaling molecule that could influence cell signaling pathways
in epithelial cells after their activation (Pendaries et al., 2005;
Wilcox and Hinchliffe, 2008; Grainger et al., 2012). Cell invasion
by bacterial pathogens such as Shigella and Salmonella induce
a high level of cellular PI5P. This increase is due to the Phos-
phoinositide 4-phosphatase activity of the virulence factors IpgD
(Shigella flexneri) (Niebuhr et al., 2002) or SigD/SopB (Salmonella
spp.) (Mason et al., 2007). PI5P has been localized in different
subcellular compartments such as the plasma membrane, endo-
plasmic reticulum, Golgi apparatus, and the nucleus (Jones et al.,
2006; Coronas et al., 2007; Sarkes and Rameh, 2010). PI5P was
detected in T cells following ectopic expression of a PI(3,5)P2 3-
phosphatase, myotubularin-1 (MTM1) (Tronchere et al., 2004).
MTM1 expression in Jurkat T cells induces a high level of cellular
PI5P as detected by PI5P mass assay. Using similar methods, we
were also able to detect a PI5P increase upon TCR triggering in the
Hut-78 T cell line (Guittard et al., 2009). Recently, direct detec-
tion of PI5P by HPLC has been described (Sarkes and Rameh,
2010). These assays require expertise in analysis of lipids; thus
these approaches are difficult to apply in cell signaling teams more
familiar with protein biochemical analysis.
Here, we will discuss of the potent effects of PI5P in T cell sig-
naling and the nature of the enzymes that could generate PI5P. We
discuss identification of some direct PI5P partners (Guittard et al.,
2009, 2010), and speculate about different protein domains that
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bind PI5P in order to dissect the potential functional role of PI5P
and to design some potential probes for PI5P as has been done
for PI(3,4,5)P3 detection with the Akt Pleckstrin Homology (PH)
domain. Finally, increase in PI5P levels could be involved; not only
in T cell signaling and gene transcription, but also in T cell chemo-
taxis (Konradt et al., 2011) and/or other cellular processes such as
vesicular trafficking and chromatin rearrangement.
PI5P SYNTHESIS DURING T CELL ACTIVATION
Measuring PIs levels requires a large amount of cellular mater-
ial. Thus, most of these experiments are performed in cell lines.
Indeed, many T cell lines harbor mutations in the PTEN gene,
which induces a high level of cellular PI(3,4,5)P3 that can induce a
bias when studying other PIs species (Astoul et al., 2001). To detect
PI5P levels in T cells, we used a wild-type PTEN human T cell line,
HUT-78. By stimulating this cell line with an anti-CD3 mAb, a
nearly fourfold PI5P increase was detected using a lipid mass assay
(Guittard et al., 2009). This fold increase is in accordance with
other reported results in response to insulin stimulation in other
cell types (Sbrissa et al., 2004; Sarkes and Rameh, 2010). As TCR-
induced PI5P elevations appear to be rapid (peaks at 2 min) and
transient (Guittard et al., 2009), we suggest that there is a rapid
recruitment of a specific lipid kinase/phosphatase to the plasma
membrane upon TCR engagement, as observed previously for the
class IA PI3K (Fabre et al., 2005). The enzyme or the enzymatic
complex involved in the PI5P increase in T cells is still unknown.
PI(4,5)P2 is found at high levels at the plasma membrane.
Thus, it represents a potent substrate for a PI(4,5)P2 4-phosphatase
resulting in PI5P synthesis. IpgD S. flexneri virulence factor, has
been clearly identified to be a PI(4,5)P2 4-phosphatase (Niebuhr
et al., 2002). Ectopic IpgD expression has been used in several stud-
ies to access the role of PI5P in eukaryotic cells (Pendaries et al.,
2006; Guittard et al., 2009, 2010; Sarkes and Rameh, 2010; Ramel
et al., 2011; Oppelt et al., 2012). So far no eukaryotic enzyme has
been identified that synthesizes only PI5P. Next we will discuss
enzymes that can lead to production of PI5P that are expressed
in T cells and may be involved in early TCR signaling. As sum-
marized in Figure 1, there are three different possible routes to
synthesize PI5P: the 5-kinases (PIKfyve), 3-phosphatases (MTMs
family members), and type I/II PI(4,5)P2 4-phosphatases.
PHOSPHOINOSITIDE 5-KINASE, PIKfyve/PIPKIII
The simplest way to produce PI5P would be a direct phosphory-
lation of PI by a phosphoinositide 5-kinase. So far, only PIKfyve
FIGURE 1 | Mammalian enzymes involved in PI5P metabolism.
has been suggested to play such a role (Sbrissa et al., 1999, 2002).
PIKfyve is a lipid 5-kinase that bears a FYVE domain that rec-
ognizes PI3P species. PIKfyve can act on two substrates, PI and
PI3P to generate PI5P and PI(3,5)P2, respectively. So far, this
is the only kinase proposed to directly produce PI5P from PI
in vitro. Moreover, PIKfyve shRNAs decrease the PI5P pool in
fibroblasts from a hypomorphic gene-trap mouse mutant (Zolov
et al., 2012). Interestingly, their observation of the early thymus
degeneration in these mice suggests a possible role for PIKfyve in
T cell development. A role in peripheral T cell functions could
be possible as PIKfyve is expressed in spleen (Zolov et al., 2012).
However, it is still difficult to understand if the thymic degen-
eration result from PI5P and/or PI(3,5)P2 loss. Recently a new
PIKfyve inhibitor,YM201636,has been identified. Unexpectedly,at
low doses (10–25 nM), it inhibited preferentially PI5P rather than
PI(3,5)P2 production in vitro, whereas at higher doses, the genera-
tion of the two lipid products were similarly inhibited. YM201636
or potential second generation molecules may represent a possible
avenue for discriminating biologic effects observed consequent to
PI5P loss versus PI(3,5)P2 loss (Sbrissa et al., 2012).
PI5P synthesis in different cell types occurs mainly at the
plasma membrane (Sarkes and Rameh, 2010). Our observations
of a rapid PI5P increase upon TCR engagement (Guittard et al.,
2009) prompted us to postulate that PI5P pools are produced at
the plasma membrane. However, PIKfyve is essentially located at
intracellular organelles where it plays a key role in vesicular trans-
port (Sbrissa et al., 2012). Therefore other enzymes should be
considered to regulate the PI5P level at the plasma membrane.
PHOSPHOINOSITIDE 3-PHOSPHATASES, MTM1, AND
MYOTUBULARIN-RELATED PROTEINS
Enzymes from the myotubularin family are 3-phosphatases that
can regulate PI3P and PI(3,5)P2 pools (Tronchere et al., 2004).
These enzymes are ubiquitously expressed (Laporte et al., 1996,
1998) and are able to generate PI5P from PI(3,5)P2 in vitro
(Schaletzky et al., 2003; Vaccari et al., 2011). They were the first
identified eukaryotic phosphatases able to produce PI5P in vivo
(Tronchere et al., 2004). However, here again, PI(3,5)P2 is thought
to be mainly localized at late endosomal membranes (De Mat-
teis and Godi, 2004). Thus, it would be difficult to consider that
MTMs enzymes are responsible for early PI5P synthesis at the
plasma membrane upon TCR stimulation.
TYPE I/II PI(4,5)P2 4-PHOSPHATASES
Two human PI(4,5)P2 4-phosphatases (type I and type II isoforms)
have been identified (Ungewickell et al., 2005; Zou et al., 2007).
They share a CX5R phosphatase motif with the IpgD prokaryotic
PI(4,5)P2 4-phosphatase (Ungewickell et al., 2005). In vitro, these
eukaryotic phosphatases are also able to convert PI(4,5)P2 to PI5P.
Both enzymes are ubiquitously expressed and localize to late endo-
somal/lysosomal membranes in epithelial cells (Ungewickell et al.,
2005). Again this makes them less likely to be involved in early
signaling from the T cell receptor. Moreover type I phosphatase
has been shown to be translocated to the nucleus where it can
increase PI5P levels following genotoxic stress (Zou et al., 2007).
Thus, this raises the possibility that these enzymes play a role in
transcriptional activity.
Frontiers in Immunology | T Cell Biology April 2013 | Volume 4 | Article 80 | 2
Nunès and Guittard PI5P in T cell biology
In conclusion, based on the claimed cellular localizations of
these enzymes or their substrates (Table 1), it is hard to imagine
a scheme inducing a major PI5P synthesis at the plasma mem-
brane. However, some of these enzymes have a role in T cells. For
example, MTMR6 could down-regulate calcium receptor KCa3.1
expressed in T and B cells, in a PI3P-dependent manner (Srivastava
et al., 2005). One cannot exclude a transient and local recruit-
ment of enzymatic complexes able to produce PI5P at the plasma
membrane. Further investigations in T cell biology studying these
proteins could define some new functions for PI5P especially in
endosomal compartments and/or in the nucleus.
PI5P BINDING DOMAINS
As mentioned above, PIs are organized into specific subcellular
compartments in order to recruit protein to a specific organelle
(McCrea and De Camilli, 2009). As summarized in Table 2, some
studies have been conducted to identify potential partners of PI5P
and, therefore, to suggest potential functions for this phospholipid.
THE PHD MOTIFS OF NUCLEAR PROTEINS, ING2 AND ATX-1
The plant homeo-domain (PHD) motif is a conserved Cys4-
HisCys3 orphan zinc finger domain present throughout eukaryotic
proteomes. A large number of chromatin regulatory factors con-
tain PHD fingers, including the ING family of putative tumor
suppressors (Feng et al., 2002; Fyodorov and Kadonaga, 2002;
Kalkhoven et al., 2002). In 2003, the PHD of ING2 protein became
the first identified PI5P-binding domain. It was identified by three
different in vitro experimental approaches by PIP-beads binding
assay, by fat-blotting, and by surface plasmon resonance (SPR)
analysis (Gozani et al., 2003). However, although binding to PI5P,
a significant binding to other mono-PIs such as PI3P could not be
excluded from this study. To strengthen this PHD motif binding
affinity, a 3X PHD motif has been generated and shows a stronger
PI5P binding. This 3X PHD ING2 construct has been used as a
tool for PI5P investigations (Pendaries et al., 2006; Guittard et al.,
2009, 2010; Ramel et al., 2011). A similar PHD motif was iden-
tified in plants. The Arabidopsis homolog of trithorax-1 (ATX-1)
binds PI5P using its PHD domain (Alvarez-Venegas et al., 2006).
Authors are suggesting a role for PI5P in inhibiting ATX-1 pro-
tein by delocalizing it from the nucleus where it can repress gene
expression. Nuclear PI5P localization has been reported and PI5P
can modify the function of some PHD motif containing proteins
(Gozani et al., 2003; Alvarez-Venegas et al., 2006; Jones et al., 2006).
A role for nuclear PI5P in regulating nuclear protein function has
not yet been assessed in T cell biology.
THE PH DOMAIN OF DOK FAMILY MEMBERS
Only 10% of known PH domains bind PIs with high specificity
(Lemmon, 2008). The first identified PH domain harboring some
PI5P binding properties was the PH domain of the p62 subunit of
the transcription factor IIH (TFIIH) (Di Lello et al., 2005). This
observation is really close to what has been reported for the PI5P
binding PHD domains, suggesting again a potential role for PI5P
in cell transcriptional activity.
Table 1 | Enzyme expression, localization, and functions in lymphoid cells.
Enzymes Substrates
in vitro
Lymphoid tissues
expression
Localization Immune function Reference
PIPK
PIPKI/PI4P
5-kinase (α, β, γ)
PI4P, PI Spl., LNs Nu (α), PM
(γ), PNu (β)
PIPKIγ in NK, Blast cells T cells,
PIPKIγ 90 is negative regulator of T
cell activation, adhesion, and
proliferation
Doughman et al. (2003), Micucci et al.
(2008), Bolomini-Vittori et al. (2009),
Vasudevan et al. (2009), Wernimont et al.
(2010)
PIPKIII/Pykfyve
(5-kinase)
PI, PI3P Spl., Thy LE KO: early degeneration of Thymus,
role in T cell development?
Zolov et al. (2012)
3-PHOSPHATASE
MTM1 PI3P,
PI(3,5)P2
LN, Spl., Thy Cyt., PM? Overexpression enhance PI5P pool
in Jurkat T cells
Laporte et al. (1996), Tronchere et al.
(2004)
MTMR2, 3, 6 PI3P,
PI(3,5)P2
Ubiquitous Cyt., PM? Not tested, but MTMR6
down-regulate KCa3.1 Ca2+ rec.
expressed on B, T cells
Laporte et al. (1998), Walker et al. (2001),
Berger et al. (2002), Schaletzky et al.
(2003), Srivastava et al. (2005), Lorenzo
et al. (2006), Vaccari et al. (2011)
4-PHOSPHATASE
Type I, II/PI(4,5)P2
phosphatase
(IpgD homolog)
PI(4,5)P2 Spl., BM, Thy., PBL LE, Ly, Nu Not tested Ungewickell et al. (2005), Zou et al. (2007)
5-PHOSPHATASE
PLIP/PTPM T1 PI5P? Spl., LNs, BM G Not tested Merlot et al. (2003), Pagliarini et al. (2004),
Zhang et al. (2011)
Nu, nucleus; PM, plasma membrane; C, cytosol; PNu, peri-nuclear; LE, late endosomes; Ly, lysosomes; G, Golgi; Spl, spleen; BM, bone marrow; Thy, thymus; PBL,
peripheral blood leukocytes.
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Table 2 | Some cellular proteins containing a lipid/protein interaction domain were identified as PI5P binding partners.
Binding domain PI binding Experiment used Protein role Reference
CYTOSOL, PLASMA MEMBRANE
PH Dok-1/Dok-2 PI4P, PI5P Fat blot, SPR Negative regulation T cell signaling Guittard et al. (2009)
PH-Dok-4 PI5P>Mono-PIs Fat blot, SPR Negative/positive regulation T cell signaling Guittard et al. (2010)
PH Dok-5 PI5P+++ Fat blot, SPR Cardiomyocyte differentiation PI3K depdt Guittard et al. (2010)
BIN1 PI5P, PI3P SPR Tubular invaginations of membranes,
biogenesis of muscle T tubules
Nicot et al. (2007),
Fugier et al. (2011)
NUCLEUS
ATX-1-PHD PI5P+++ Fat blot Plant (Arapidopsis thaliana) chromatin
modification stress induced
Alvarez-Venegas et al.
(2006)
ING2 PHD PI5P+, PI3P Fat blot, SPR, PIP-beads Nucleus cellular stress response Gozani et al. (2003)
Sap30L/Sap 30 PI5P>PI3P>PI4 Fat blot Chromatin remodeling, transcription Viiri et al. (2009)
PH-tfb1 TFII subunit PI5P, PI3P Fat blot Transcription factor Di Lello et al. (2005)
Different experimental approaches were used to characterize this PI5P binding. These proteins are expressed in different subcellular compartments and are involved
in different cell functions. PH, Pleckstrin homology domain; PHD, plant homeo-domain; SPR, surface plasmon resonance.
Dok (for downstream of kinase) proteins are adaptor proteins
that are expressed in lymphocytes (Favre et al., 2003). Upon T cell
stimulation, these PH domain-containing proteins are recruited
to (or are in the vicinity of) the plasma membrane (Boulay et al.,
2005; Gerard et al., 2009). Dok-1 and Dok-2 PH domains were
shown to bind PI5P and PI4P in SPR analysis (Guittard et al.,
2009). But using different enzymatic approaches, PI5P appeared
to be essential for Dok proteins tyrosine phosphorylation. More-
over, PI5P binding domain expression (Dok-1 PH domain or 3X
PHD ING2) block PI5P-induced Dok phosphorylation.
Among Dok family PH domains (Favre et al., 2003), the PH
domain of Dok-5 revealed the highest PI5P binding affinity in
SPR experiments (Guittard et al., 2009, 2010). Dok-5 PH domain
expression reduced IpgD-induced IL-2 promoter activity in T cells
by sequestering PI5P within the cell (Guittard et al., 2010). These
observations highlighted PI5P as a newly identified actor in T cell
signaling that acts by regulating cytosolic Dok proteins.
A ROLE FOR PI5P IN T CELL SIGNALING
Stimulation of membrane receptors such as the TCR on T cells
induces the activation of protein tyrosine kinases (PTKs) and sub-
sequently the phosphorylation of substrates, which contributes
to the formation of a cytoplasmic multiprotein network (Smith-
Garvin et al., 2009). TCR leads to the activation of several physi-
cally separated protein modules (Figure 2). First, Src-family pro-
tein tyrosine kinases (SFK) Lck/Fyn are activated by a yet not fully
known mechanism. SFK activation is followed by tyrosine phos-
phorylation of TCR and CD3 chains leading to the recruitment of
ZAP-70 PTK. Finally, cytoplasmic protein networks are established
based on interactions with numerous adaptor proteins including
LAT (Acuto et al., 2008).
Dok-5 PH expression selectively reduces some TCR-induced
signaling events such as SFK activation (Lck/Fyn) and Akt
phosphorylation (AKT is a PI3K effector) (Guittard et al., 2010).
Independently of TCR engagement, ectopic expression of IpgD
induces the phosphorylation of SFK family members and Akt
(Guittard et al., 2010). Thus, PI5P could be a part of membrane
signaling TCR-containing modules, such as the SFK regulation
module (Acuto et al., 2008; Nika et al., 2010).
These SFKs are controlled by membrane lipid content (lipid
rafts). The presence of Csk and CD45 protein tyrosine phos-
phatase (PTP) is involved in maintaining a balance between active
and inactive SFK forms (Acuto et al., 2008). The selective inhibi-
tion of Csk activates this early SFK signaling module leading to
Dok-1 tyrosine phosphorylation. This suggests that PI5P could
be involved in SFK-containing lipid rafts, perhaps by modulating
the dynamics of these plasma membrane structures (Schoenborn
et al., 2011). Involvement of a PH containing molecule, such as
SKAP-55, could also bring CD45 in close proximity to the SFK
signaling module leading to its activation (Wu et al., 2002).
It has long been known that PI3K signaling is activated upon
TCR triggering (Ward et al., 1992). However, it is always diffi-
cult to draw a general connection map of proximal TCR signal-
ing pathways that integrates the PI3K/Akt pathway (Acuto et al.,
2008; Smith-Garvin et al., 2009). A possible explanation would
be that the PI3K/Akt signaling module is also physically inde-
pendent of other proximal TCR signaling modules (Acuto et al.,
2008). The full activation of Akt is dependent upon its presence
in some membrane structures corresponding to lipid raft nan-
odomains (Lasserre et al., 2008). Several reports described PI5P
acting upstream of the PI3K/Akt pathway (Carricaburu et al.,
2003; Pendaries et al., 2006; Grainger et al., 2012). For instance,
IpgD-produced PI5P persistently activates PI3K/Akt signaling in
epithelial cells (Pendaries et al., 2006). In this condition, PI5P at
the plasma membrane at the early stages of S. flexneri infection is
rapidly enriched in endosomes and alters growth factor receptor
signaling by impairing lysosomal degradation, a property used by
the pathogen to favor survival of host cells. Thus far, there is no
direct link between PI5P generation and PI3K activation in T cells.
As it is the case for the SFK regulation module, we can hypothesize
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FIGURE 2 | PI5P as a new key player inTCR signaling. TCR stimulation
induces PI5P increase (Guittard et al., 2009). By expressing a bacterial
PI(4,5)P2 4-phosphatase, IpgD in T cells, the PI5P elevation reveals a
selective activation of signaling events such as the activation of Src-family
protein tyrosine kinases (SFK) and the Ser/Thr kinase, Akt (a PI3K effector)
(Guittard et al., 2010). As previously illustrated (Acuto et al., 2008), some
physically independent signaling modules in the T cell membranes could
be involved in establishing full TCR signals, when there are
interconnected. In this scheme, we added a separated module for
PI3K/Akt signaling where the Class IA PI3K could recognize a SFK or some
membrane protein containing a Tyr-x-x-Met motif. Plasma membrane PI5P
could participate to the lipid compounds of some of these modules such
as SFK regulation module and PI3K-dependent signal
diversification/regulation module (see text).
that PI5P could participate in lipid raft nanodomains dynam-
ics where PI3K/Akt activation would take place. This potential
PI3K/Akt module could also explain why PI5P elevation provokes
a Dok protein tyrosine phosphorylation (Guittard et al., 2009), as
the PTK Tec, a PI3K effector in T cells, phosphorylates the Dok-1
and Dok-2 proteins (Yang et al., 2001; Gerard et al., 2004).
It has been reported that PI5P and other PIs interact with high
affinity to a TCR ζ basic-rich stretch (DeFord-Watts et al., 2011).
The elimination of PIs-binding regions significantly impaired the
ability of TCR ζ chains to be stably expressed at the plasma mem-
brane (DeFord-Watts et al., 2011). Taken together,a role for PI5P in
T cell signaling should be further investigated in these potentially
physically independent modules, for instance via experiments
evaluating membrane fluidity and dynamics (Lasserre et al., 2008).
OTHER PERSPECTIVES FOR A ROLE OF PI5P IN T CELL
BIOLOGY
Cell fractionation has revealed that a major fraction of PI5P is in
the plasma membrane (Sarkes and Rameh, 2010). As discussed
above, membrane PI5P is involved in T cell signaling (Guittard
et al., 2009, 2010). This lipid could also be involved in the control of
T cell migration. Indeed, S. flexneri is able to infect activated T cells
and IpgD [converting PI(4,5)P2 into PI5P] inhibits chemokine-
induced T cell migration (Konradt et al., 2011). In this study, the
authors concluded that the T cell chemotaxis block was due to a
PI(4,5)P2 breakdown. But they could not exclude a role for PI5P
increase in this process. However, in other cell types, PI5P increases
appear to induce cell migration (Oppelt et al., 2012). These appar-
ent discrepancies likely result from differences between lymphoid
cells and other cell types in their cell migration. For instance, many
cell types use a PI3K-dependent pathway in inducing cell migra-
tion, but T cell chemotaxis seems to be independent of a PI3K
signaling pathway (Asperti-Boursin et al., 2007). The Rac small
GTPase, probably regulated by DOCK2 RacGEF, could drive this
T cell migration (Fukui et al., 2001). One exiting hypothesis would
be that PI5P is involved in a Rac-dependent pathway and/or par-
ticipates in the connection between plasma membrane and the
cytoskeleton dynamics.
In skeletal muscle, the bridging integrator-1 (BIN1) proteins
bind to membrane PI5P and is involved in tubular invaginations of
membranes and is required for the biogenesis of muscle T tubules
(Nicot et al., 2007; Fugier et al., 2011). PI5P can be detected in
endosomes (Sarkes and Rameh, 2010) and can favor RTK signaling
prolongation in early endosomes (Ramel et al., 2011). Further-
more IpgD expression induces a striking amount of IL-2 promoter
activity in T cells (Guittard et al., 2010). These results could be due
to sustained T cell signaling at the plasma membrane or in intracel-
lular compartments. Thus, the role of PI5P in vesicular trafficking
in T cells should be considered.
In summary, PI5P is now taking its place in T cell biology.
As in other mammalian cell types, the localization of basal and
inducible PI5P should be characterized by cell fractionation fol-
lowed by lipid composition analysis. PI5P-specific probes should
be improved to visualize phospholipid dynamics upon T cell acti-
vation. Further investigations should be performed to assess the
exact role of PI5P at the plasma membrane (for T cell signal-
ing and migration), but also in vesicular trafficking and nuclear
function.
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